LeeCampbellDrinkardMDFACP

Oncology • Irving, TX

Gastrointestinal Cancer, Hematologic Oncology, Hospice & Palliative

Hematology/Oncology

Join to view full profile

Dr. Drinkard is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Drinkard's full profile

Already have an account?

Office
568 Via Amalfi
Irving, TX 75039
Phone+1 817-291-3695
Is this information wrong?

Summary

Dr. Lee Drinkard is an oncologist at DHR Oncology Institute in Edinburg, TX. He received his medical degree from West Virginia University School of Medicine and has been in practice for 30 years. He specializes in Medical Oncology with special interests in clinical trials, drug development, thoracic, breast and hematologic oncology.

Education & Training

University of ChicagoFellowship, Hematology and Medical Oncology, 1991 - 1994
George Washington UniversityResidency, Internal Medicine, 1987 - 1990
West Virginia University School of MedicineClass of 1987

Certifications & Licensure

CA State Medical License 1994 - Present
MO State Medical License 2024 - 2025
TX State Medical License 1997 - 2024
KS State Medical License 2024 - 2024
IL State Medical License 1990 - 2002
WV State Medical License 1990 - 1992
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Hospice and Palliative Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Fellow American College of Physicians American College of Physicians, 1995

Publications & Presentations

PubMed

When Two Worlds Collide: A Rare Case of Multiple Myeloma With Extramedullary Plasmacytoma.
Nadal Bosch, J., Malcolm, J., Moya, M., Serna, S., Drinkard, L.> ;Cureus. 2023 Dec 1
16 citations
Phase I study of vinorelbine and ifosfamide in advanced non-small-cell lung cancer.
Gregory A. Masters, Philip C. Hoffman, Ai-ly Hsieh, L. C. Drinkard, Rosemarie Mick, Brian L. Samuels, Alfred Guaspari, Harvey M. Golomb, Everett E. Vokes> ;Journal of Clinical Oncology. 1997 Mar 1
6 citations
Hodgkin lymphoma transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma
John R. Krause, Lee C. Drinkard, Latoya Keglovits> ;Proceedings. 2013 Jan 1
18 citations
Acute Myelomonocytic Leukemia with Abnormal Eosinophils Presenting as an Ovarian Mass: A Report of Two Cases and a Review of the Literature
Lee C. Drinkard, Steven E Waggoner, Robert Stein, Rebecca A. Byrne, Richard A. Larson> ;Gynecologic Oncology. 1995 Feb 1
87 citations
tRNA nuclear transport: defining the critical regions of human tRNAimet by point mutagenesis.
Janet Ash Tobian, Lee Drinkard, Michael Zasloff> ;Cell. 1985 Dec 1
Multimodality therapy for locally advanced and limited stage IV breast cancer: the impact of effective non-cross-resistance late-consolidation chemotherapy.
Blumenschein, G. R., DiStefano, A., Caderao, J., Fristenberg, B., Adams, J., Schweichler, L. H., Drinkard, L.> ;Clin Cancer Res. 1997 Dec
4 citations
Insecticide-induced lupus erythematosus.
Kenneth Beer, Allan L. Lorincz, Maria Medenica, John Albertini, Joseph M. Baron, L. C. Drinkard, Timothy J. Swartz> ;International Journal of Dermatology. 1994 Dec 1
13 citations
Intensive multimodality therapy for carcinoma of the esophagus and gastroesophageal junction
Mark K. Ferguson, Laurie B. Reeder, Philip C. Hoffman, Daniel J. Haraf, L. C. Drinkard, Everett E. Vokes> ;Annals of Surgical Oncology. 1995 Mar 1
2 citations
Paclitaxel and ifosfamide: a multicenter phase I study in advanced non-small cell lung cancer.
Philip C. Hoffman, Stuart A. Krauss, L. C. Drinkard, Gregory A. Masters, Brian L. Samuels, Jacob D. Bitran, Harvey M. Golomb, S. Watson, Everett E. Vokes> ;Seminars in Oncology. 1995 Aug 1
4 citations
Dose intensification--a phase I study of ifosfamide with vinorelbine (Navelbine): rationale and study design in advanced non-small cell lung cancer.
L. C. Drinkard, Philip C. Hoffman, Brian L. Samuels, S. Watson, Jacob D. Bitran, Harvey M. Golomb, Everett E. Vokes> ;Seminars in Oncology. 1995 Apr 1
6 citations
A phase I trial of concomitant chemoradiotherapy with cisplatin dose intensification and granulocyte-colony stimulating factor support for advanced malignancies of the...
Everett E. Vokes, Daniel J. Haraf, L. C. Drinkard, Philip C. Hoffman, Mark K. Ferguson, N. J. Vogelzang, S. Watson, N. J. Lane, Harvey M. Golomb> ;Cancer Chemotherapy and Pharmacology. 1995 Jul 1
9 citations
Induction chemotherapy, surgery, and concomitant chemoradiotherapy for carcinoma of the esophagus: A long-term analysis
Philip C. Hoffman, Daniel J. Haraf, Mark K. Ferguson, L. C. Drinkard, E. E E.Vokes> ;Annals of Oncology. 1998 Jun 1
46 citations
Phase I study of vinorelbine, cisplatin, and concomitant thoracic radiation in the treatment of advanced chest malignancies.
Gregory A. Masters, Daniel J. Haraf, Philip C. Hoffman, L. C. Drinkard, Stuart A. Krauss, Mark K. Ferguson, Jemi Olak, Brian L. Samuels, Harvey M. Golomb, Everett E. V...> ;Journal of Clinical Oncology. 1998 Jun 1
5 citations
A review of ifosfamide and vinorelbine in advanced non-small cell carcinoma of the lung
Gregory A. Masters, Philip C. Hoffman, L. C. Drinkard, Brian L. Samuels, Harvey M. Golomb, Everett E. Vokes> ;Seminars in Oncology. 1998 Feb 1
A phase I-phase II study of vinorelbine with cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancer.
Gregory A. Masters, L. C. Drinkard, Philip C. Hoffman, N. J. Lane, S. Watson, Brian L. Samuels, Jacob D. Bitran, Harvey M. Golomb, Everett E. Vokes> ;The Cancer Journal from Scientific American. 1995 Nov 1
14 citations
Ifosfamide plus paclitaxel in advanced non-small-cell lung cancer: A phase I study
Philip C. Hoffman, Gregory A. Masters, L. C. Drinkard, Stuart A. Krauss, Brian L. Samuels, Harvey M. Golomb, Everett E. Vokes> ;Annals of Oncology. 1996 Mar 1
4 citations
Ifosfamide-based chemotherapy for non-small cell lung cancer: phase I/II studies at the University of Chicago.
Everett E. Vokes, Philip C. Hoffman, Gregory A. Masters, Harvey M. Golomb, L. C. Drinkard, Stuart A. Krauss> ;Seminars in Oncology. 1996 Jun 1
3 citations
Ifosfamide-based combination chemotherapy in advanced non-small cell lung cancer: two phase I studies.
Philip C. Hoffman, Gregory A. Masters, L. C. Drinkard, Stuart A. Krauss, Brian L. Samuels, Harvey M. Golomb, Everett E. Vokes> ;Seminars in Oncology. 1996 Jun 1
7 citations
Vinorelbine (Navelbine), cisplatin, and concomitant radiation therapy for advanced malignancies of the chest: a Phase I study.
Everett E. Vokes, Daniel J. Haraf, Gregory A. Masters, Philip C. Hoffman, L. C. Drinkard, Mark K. Ferguson, Jemi Olak, S. Watson, Harvey M. Golomb> ;Seminars in Oncology. 1996 Apr 1
2 citations
Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer.
Gregory A. Masters, Philip C. Hoffman, L. C. Drinkard, S. Watson, Brian L. Samuels, Harvey M. Golomb, Everett E. Vokes> ;Seminars in Oncology. 1996 Apr 1
4 citations
A phase II study of cisplatin, 5-fluorouracil, and leucovorin augmented by vinorelbine (Navelbine) for advanced non-small cell lung cancer: rationale and study design.
Everett E. Vokes, L. C. Drinkard, Brian L. Samuels, Philip C. Hoffman, S. Watson, Jacob D. Bitran, Daniel J. Haraf, Ferguson Mf, Harvey M. Golomb> ;Seminars in Oncology. 1994 Oct 1
Join now to see all

Press Mentions

Oncologist, Fire Chief Stress Safety of COVID Vaccine for Cancer PatientsJanuary 6th, 2021

Professional Memberships

American Academy of Hospice and Palliative Medicine - AAHPM
Member
American College of Physicians - ACP
Fellow
American Society of Clinical Oncology - ASCO
Member
American Society of Hematology - ASH
Member

Other Languages

Spanish